What patients say Rated 4.9 across thousands of patients, and recommended in Reddits GLP-1 communities
Further long-term studies are required to confirm this result, particularly in patients with diabetes mellitus
BPC-157s evidence base is also concentrated in a single research group (Sikiric and colleagues, University of Zagreb) with limited independent replication
to reduce the risk of major adverse cardiovascular events (cardiovascular death, non-fatal myocardial infarction or non-fatal stroke) in adults with type 2 diabetes and established cardiovascular disease
Current evidence shows that GLP-1 receptor agonists have no negative effects on the cardiovascular risk of patients with T2D
In fact, partial hepatectomy induces a rapid postoperative decline of lean- and adipose tissue mass paralleled by a concomitant increase in accumulation of lipids in the regenerating liver in rodents, leading to transient steatosis 2,3